Scilex Holding Co (SCLX) stock
SCLXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLXW
$1.56−0.06 (-3.70%)
Close on Nov 12, 2026Market cap $13.25MP/E –Yield –
Scilex enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Scilex's enterprise value was $89.40M on Nov 10, 2026, against $163.11M a year earlier. Over the last 5 years it ranged from $11.28M to $1.38B, with a median of $138.81M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $89.40M | -22.0% |
| 2025 | Dec 31, 2025 | $114.58M | -13.6% |
| 2024 | Dec 31, 2024 | $132.69M | -56.5% |
| 2023 | Dec 29, 2023 | $305.24M | +2605.4% |
| 2022 | Dec 30, 2022 | $11.28M | -54.9% |
| 2021 | Dec 31, 2021 | $25.01M | – |
See a number that looks wrong?